Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rotigotine in pediatric RLS
NCT01495793Phase 2Completed
- Sponsor
- UCB
- Start
- Dec 2011
- Primary completion
- May 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of rotigotine in restless legs syndrome (RLS), sponsored by UCB. Started Dec 2011; status: completed.
02
Drugs
rotigotine
03
Conditions
restless legs syndrome (RLS)
Beyond the preview
Go deeper on NCT01495793.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01495793.